Log In
BCIQ
Print this Print this
 

levetiracetam extended-release (Elepsia XR)

  Manage Alerts
Collapse Summary General Information
Company Sun Pharma Advanced Research Company Ltd.
DescriptionExtended-release levetiracetam, a high affinity synaptic vesicle protein (SV2A) ligand, using Wrap Matrix technology
Molecular Target Synaptic vesicle protein (SV2A)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationEpilepsy
Indication DetailsTreat epilepsy
Regulatory Designation
PartnerSun Pharmaceutical Industries Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$10.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/18/2016

Undisclosed

$10.0M

Undisclosed

Get a free BioCentury trial today